Encainide
From Wikipedia, the free encyclopedia
 |
|
|
Encainide
|
|
| Systematic (IUPAC) name | |
| 4-methoxy-N-[2-[1-methyl-2- (1-piperidyl)ethyl] phenyl]-benzamide | |
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C22H28N2O2 |
| Mol. mass | 352.47 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Encainide is a class Ic antiarrhythmic agent. Is is no longer used because its frequent proarrhythmic side effects.
|
|
|
|---|---|
| class Ia | Ajmaline, Disopyramide, Prajmaline, Procainamide, Quinidine, Sparteine |
| class Ib | Aprindine, Lidocaine, Mexiletine, Tocainide |
| class Ic | Encainide, Flecainide, Lorcainide, Moricizine, Propafenone |
| class II | Propranolol, Metoprolol, Nadolol, Atenolol, Acebutolol, Pindolol see Beta blockers (C07) |
| class III | Amiodarone, Bretylium tosylate, Bunaftine, Dofetilide, Ibutilide, Sotalol |
| class IV | Verapamil, Diltiazem see Calcium channel blockers (C08) |
| class V | Adenosine, Atropine, Digoxin |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
